IRIS
MAGNI, PAOLO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 15.588
AS - Asia 11.683
EU - Europa 9.805
SA - Sud America 1.714
AF - Africa 367
OC - Oceania 29
Continente sconosciuto - Info sul continente non disponibili 27
Totale 39.213
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 15.180
CN - Cina 5.729
SG - Singapore 2.550
IE - Irlanda 2.251
BR - Brasile 1.302
IT - Italia 1.261
RU - Federazione Russa 1.184
HK - Hong Kong 1.114
DE - Germania 1.065
VN - Vietnam 1.052
UA - Ucraina 989
FI - Finlandia 895
FR - Francia 624
GB - Regno Unito 497
SE - Svezia 457
IN - India 315
CA - Canada 216
ZA - Sudafrica 213
AR - Argentina 160
MX - Messico 130
BD - Bangladesh 127
IQ - Iraq 111
BE - Belgio 107
JP - Giappone 101
PL - Polonia 86
NL - Olanda 75
ES - Italia 73
TR - Turchia 69
EC - Ecuador 68
CO - Colombia 59
PK - Pakistan 58
AT - Austria 50
IR - Iran 45
ID - Indonesia 43
VE - Venezuela 42
MA - Marocco 38
UZ - Uzbekistan 38
SA - Arabia Saudita 37
MY - Malesia 33
CZ - Repubblica Ceca 32
CL - Cile 31
PH - Filippine 30
CH - Svizzera 29
JO - Giordania 26
LT - Lituania 23
EU - Europa 22
AU - Australia 21
IL - Israele 19
NP - Nepal 19
TN - Tunisia 18
AZ - Azerbaigian 17
GR - Grecia 17
AE - Emirati Arabi Uniti 16
EG - Egitto 16
ET - Etiopia 16
KZ - Kazakistan 16
PE - Perù 16
DO - Repubblica Dominicana 14
BO - Bolivia 13
KE - Kenya 13
KR - Corea 13
RO - Romania 13
DZ - Algeria 12
LV - Lettonia 12
TH - Thailandia 12
AL - Albania 11
UY - Uruguay 11
JM - Giamaica 10
PY - Paraguay 10
PS - Palestinian Territory 9
QA - Qatar 9
AM - Armenia 8
CR - Costa Rica 8
LB - Libano 8
OM - Oman 8
KG - Kirghizistan 7
LK - Sri Lanka 7
BG - Bulgaria 6
HU - Ungheria 6
NI - Nicaragua 6
NZ - Nuova Zelanda 6
SN - Senegal 6
BB - Barbados 5
GE - Georgia 5
HR - Croazia 5
KW - Kuwait 5
NG - Nigeria 5
PT - Portogallo 5
RS - Serbia 5
BY - Bielorussia 4
CI - Costa d'Avorio 4
DK - Danimarca 4
LA - Repubblica Popolare Democratica del Laos 4
NO - Norvegia 4
PA - Panama 4
SI - Slovenia 4
SY - Repubblica araba siriana 4
XK - ???statistics.table.value.countryCode.XK??? 4
BH - Bahrain 3
GT - Guatemala 3
Totale 39.143
Salva come PNG Salva come JPEG
Città #
Dublin 2.247
Chandler 2.067
Dallas 1.454
Singapore 1.450
Jacksonville 1.303
Ashburn 1.290
San Jose 1.263
Nanjing 1.147
Hong Kong 1.077
Beijing 1.007
Boardman 695
Nanchang 482
Los Angeles 414
Ho Chi Minh City 383
Princeton 365
Lauterbourg 363
Lawrence 354
Pavia 354
Wilmington 347
New York 342
Ann Arbor 326
Changsha 326
Helsinki 313
Shenyang 310
Hebei 309
Dearborn 304
Medford 302
Hanoi 262
Shanghai 252
Moscow 249
Jiaxing 245
Munich 218
Milan 215
Tianjin 196
Hangzhou 190
Johannesburg 180
Buffalo 173
Redondo Beach 163
São Paulo 135
Orem 118
Toronto 102
Brussels 99
Turku 99
Tokyo 92
Santa Clara 86
Woodbridge 86
Seattle 77
Norwalk 71
Chennai 69
Frankfurt am Main 68
Warsaw 68
Verona 63
London 60
Montreal 59
Brooklyn 58
Atlanta 55
Guangzhou 55
Denver 54
Piscataway 52
Council Bluffs 50
Kunming 49
Da Nang 47
Rome 46
Falkenstein 45
Mexico City 45
Nuremberg 45
Stockholm 45
Chicago 44
San Francisco 44
Jinan 43
Florence 42
Houston 41
Boston 40
Haiphong 38
Amsterdam 36
Phoenix 36
Poplar 35
Tashkent 35
Baghdad 34
Mumbai 34
Ningbo 34
Zhengzhou 34
Rio de Janeiro 33
Fairfield 32
Manchester 31
Des Moines 28
Washington 28
Brasília 26
Dhaka 25
Hefei 25
Vienna 25
Basingstoke 24
Biên Hòa 24
Quito 24
Hải Dương 23
Zurich 23
Belo Horizonte 22
New Delhi 22
Paris 22
Amman 21
Totale 25.963
Salva come PNG Salva come JPEG
Nome #
An automatic implementation of ACMG/ClinGen guidelines for constitutional Copy Number Variants annotation and interpretation 201
A comparison of eVai, CADD and VVP variant prediction results on the ICR639 hereditary cancer dataset 200
Living Materials for the Detection of Volatile Compounds to Monitor Agroindustrial Processes 189
Analysis of amplicon-based NGS data from neurological disease gene panels: a new method for allele drop-out management 181
2 month evening and night closed-loop glucose control in patients with type 1 diabetes under free-living conditions: A randomised crossover trial 179
Quantitative evaluation of RC-106 antitumor activity in GBM spheroids through tumor growth inhibition modeling based on cell counts data 173
A Bayesian method for clustering gene expression temporal profiles from microarray data 164
A Bayesian approach to non-parametric AUC estimation in population studies 162
A novel method for proteomic analysis of immunoglobulin light chains and attribution to a germline gene-based family 161
A Markov decision process: screening hereditary hemochromatosis 160
DIVAs: a phenotype-based machine-learning model to assess the pathogenicity of digenic variant combinations 157
Phenotypes extraction from clinical descriptions using Large Language Models 155
A non parametric population approach for selecting biomarkers of a drug action 152
Astrazioni temporali per il clustering di profili di espressione genica 151
An integrative pathology workflow to enhance molecular diagnostics in precision oncology 149
Clinical classification of myelofibrosis with myeloid metaplasia (MMM): cluster analysis of 861 patients enrolled into a nationwide prospective registry (RIMM) 147
A Perl procedure for the analysis of phosphopeptide tandem mass spectra 144
Methods for the analysis of mass spectrometry data in proteomics 144
A standard vector for the chromosomal integration and characterization of BioBrick™ parts in Escherichia coli 144
Ethanol? Whey not! 143
Protein identification by peptide mass fingerprinting: a perl procedure 141
OPTIMIZATION OF GAMMA-PGA BIOSYNTHESIS SUPPORTED BY SYNTHETIC BIOLOGY AND METABOLIC ENGINEERING STRATEGIES 141
Improving protein identification by MsPI using peak intensity 140
Mathematical models of tumor growth inhibition in xenograft mice after administration of anticancer agents given in combination 140
A PK-PD model of tumor growth after administration of an anti-angiogenic agent given alone or in combination therapies in xenograft mice 140
Evaluation of the T-IDDM Project in Pavia 140
Phosphopeptide identification: an automated Perl procedure 139
A BioBrick-compatible Vector for Allelic Replacement Using the XylE Gene as Selection Marker 138
A mathematical model for assessing the glucose time course in critically ill patients 137
A bioinformatic approach to predict the cross-kingdompotential of plant miRNA in humans 137
A Perl procedure to improve the efficiency of the identification and characterization of phosphopeptides 136
Integration of enzymatic data in Bacillus subtilis genome-scale metabolic model improves phenotype predictions and enables in silico design of poly-γ-glutamic acid production strains 136
A data mining approach to evaluate the performance of recruitment centres in antidepressant drug clinical trials 135
An energy based model able to describe the effect of anticancer drugs on tumor growth and host body weight 135
In-Silico and in-Vivo Metabolic Engineering Strategies to Optimize Waste Bioconversion Pathways in Microbial Strains: Two Case Studies on Ethanol and Poly-Gamma-Glutamic Acid Biosynthesis 135
Movement detection from a wearable system: a deconvolution-based approach 134
Precedence Temporal Networks from Gene Expression Data 133
A tumor growth inhibition model in drugs combination regimens 133
A procedure to decompose high resolution mass spectra 133
A Bayesian nonparametric approach to AUC determination in population studies 133
A Perl procedure for protein identification by Peptide Mass Fingerprinting 132
Bottom-up engineering of biological systems through standard bricks: a modularity study on basic parts and devices 132
A methodology for the reliable analysis of amplicon-based NGS data 132
A mathematical model to study the effects of drugs administration on tumor growth dynamics 132
A Bioinformatics Approach to Explore MicroRNAs as Tools to Bridge Pathways Between Plants and Animals. Is DNA Damage Response (DDR) a Potential Target Process? 132
Learning Gene Regulatory Networks with an Intelligent Data Analysis Approach: An Application to the Yeast Cell Cycle 131
In vitro cell growth pharmacodynamic studies: a new nonparametric approach to determining the relative importance of drug concentration and treatment time 131
Characterization of a synthetic bacterial self-destruction device for programmed cell death and for recombinant proteins release 130
'Indolent' myelofibrosis with myeloid metaplasia: specific clinical features and prognosis 130
Integrative analysis of heterogeneous high-throughput transcriptomic data for promoter selection in bacterial genomes to support microbial synthetic biology 129
Bottom-up design of genetic circuits: characterization and re-use of biological building blocks to engineer predictable systems 129
Analisi di dati di DNA microarray: reti di regolazione 129
Methods and tools for multiscale modelling in Systems Pharmacology: a review 128
Optimization of γ-PGA biosynthesis supported by synthetic biology and metabolic engineering strategies 128
Biologia sintetica e standardizzazione: verso la programmazione razionale di funzioni biologiche artificiali 126
Three thiamine analogues differently alter thiamine transport and metabolism in nervous tissues: an in vivo kinetic study using rats 126
Learning Rules with Complex Temporal Patterns in Biomedical Domains 125
Study of energetic interactions between the tumor and host to assess the efficacy of an anticancer drug: a new mathematical model 124
Design and implementation of a negative feedback controller in E. coli with a bottom-up approach 124
Genome-wide gene expression in aneurysmal aortic walls of patients with Marfan Syndrome (MFS) and Loeys-Dietz Syndromes (LDS) with known causative mutations 124
Precedence Temporal Networks: a New Tool for Extracting Temporal Relationships in Gene Expression Profiles 123
Conversion of industrial bio-waste into biofuels through Syntetic Biology supported by flow cytometry 123
Characterization of promoter strength varying the DNA copy number from one to hundreds of copy 123
Modeling myelosuppression in patients treated with anticancer drugs 122
Characterization of a synthetic luxR-HSL repressible promoter for the design of novel activation-repression circuits in E. coli 122
Analysis of intergenic conserved sequences in the POF critical region on X chromosome 121
Analisi di dati di DNA microarray: fondamenti, selezione di geni, classificazione 121
Predicting Aqueous and Intrinsic Solubility of Pharmaceutical Molecules with Neural Networks 121
A new population PK/PD model to assess the myelotoxicity of candidate drugs in preclinical and in clinical studies 120
A Minimal Model of Tumor Growth Inhibition in Combination Regimens under the Hypothesis of no Interaction between Drugs 120
A predictive pharmacokinetic-pharmacodynamic model of tumor growth kinetics in xenograft mice after administration of anticancer agents given in combination 120
Statistical methods to detect immune responses to drug administration 119
Online Microreactor Titanium Dioxide RPLC-LTQ-Orbitrap MS Automated Platform for Shotgun Analysis of (Phospho) Proteins in Human Amniotic Fluid 119
Day-and-night closed-loop glucose control in patients with type 1 diabetes under free-living conditions:results of a single-arm 1-month experience compared with a previously reported feasibility study of evening and night at home 119
CTRL + E.: Signalling is Nothing Without Control 119
Engineering endogenous fermentative routes in ethanologenic Escherichia coli W for bioethanol production from concentrated whey permeate 119
Heart rate correction of the QT interval: a nonparametric individualized approach 118
Qualitative Representation and Clustering of Biomedical Time Series 117
Artificial intelligence and machine learning: just a hype or a new opportunity for pharmacometrics? 117
Accurate peak list extraction from proteomic mass spectra for identification and profiling studies 117
Precedence Temporal Networks: Extraction and Representation of Temporal Relationships in Gene Expression Profiles 116
Methods for genetic optimization of biocatalysts for biofuel production from dairy waste through synthetic biology 116
A metabolic engineering approach to improve ethanol production from dairy waste by optimized Escherichia coli 116
Optimal age and strategy for screening hereditary hemochromatosis. The answers from a Markov decision process 115
Characterization of promoter strength at different DNA copy numbers using RPU approach 115
Modeling the effects of promoter and regulator copy number variation on the output of inducible systems in engineered genetic circuits 115
Mathematical modeling of growth and death dynamics of mouse embryonic stem cells irradiated with gamma-rays 115
Evaluation of software tools for Bayesian estimation on population models with count and continuous data 115
Leveraging Two-Stage delta Global Sensitivity Analysis method to inform parameter estimation in PBPK models 114
Engineering signal processing pathways in living cells: from logic gates to logic funtions 114
Tumor growth modelling for drug development 114
Evaluation of software tools for Bayesian estimation on population models:an update based on current software versions 114
MsPI: A software tool for protein identification by PMF 113
Identification of phosphorylated peptides by MS/MS 113
BioBrick, standard assembly e registro delle parti biologiche standard 113
Characterization of promoter strength at different DNA copy numbers using RPUs 113
Plasma concentrations of the enantiomers of fluoxetine and norfluoxetine sources of variability and preliminary observations on relations with clinical response. 112
Analisi di dati di spettrometria di massa finalizzata alla scoperta di biomarcatori 112
MsPI: a tool for the analysis of peptide mass fingerprinting data 112
Testing additivity of anticancer agents in pre-clinical studies: A PK/PD modelling approach 112
Totale 13.245
Salva come PNG Salva come JPEG
Categoria #
all - tutte 146.477
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 146.477
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021632 0 0 0 0 0 0 0 0 0 316 240 76
2021/20221.798 46 25 91 26 23 39 52 126 95 48 297 930
2022/20235.952 651 527 83 416 567 520 17 328 2.564 36 137 106
2023/20242.397 227 459 106 163 169 505 133 171 31 64 115 254
2024/20256.165 122 590 193 202 219 225 260 412 1.536 198 707 1.501
2025/202613.897 1.263 1.168 1.866 1.775 1.959 664 2.563 553 1.227 859 0 0
Totale 39.755